HSPE1 enhances aerobic glycolysis to promote progression of lung adenocarcinoma
- PMID: 38878504
- DOI: 10.1016/j.mrfmmm.2024.111867
HSPE1 enhances aerobic glycolysis to promote progression of lung adenocarcinoma
Abstract
Objective: This study aimed to explore the role of heat shock protein family E member 1 (HSPE1) in the metabolism of lung adenocarcinoma (LUAD) cells.
Methods: Bioinformatics analysis was applied to examine the expression of HSPE1 in LUAD and its correlation with patient survival. Single-gene Gene Set Enrichment Analysis was conducted for HSPE1. LUAD cell lines or mouse models with up-regulated/down-regulated HSPE1 were constructed. The expression level of HSPE1 was detected by qRT-PCR or immunohistochemical staining. We used CCK-8 assay to measure cell viability and flow cytometry to detect apoptosis levels. Transwell assay was performed to evaluate migration and invasion characteristics. Extracellular Flux Analyzer was employed to detect oxygen consumption rate and extracellular acidification rate. Glucose consumption, adenosine triphosphate production, and lactate levels were measured by Reagent kits. Western blot analysis was conducted to examine the expression levels of GLUT1, HK2, and LDHA.
Results: HSPE1 promoted proliferative, migratory, and invasive abilities, and inhibited apoptosis of LUAD cells through the aerobic glycolysis pathway. Specifically, LUAD cells with HSPE1 knockdown exhibited significantly decreased proliferation, migration, and invasion abilities, along with an increased apoptosis rate. Additionally, the expression levels of aerobic glycolysis-related proteins HK2, LADH, and GLUT1 were downregulated, while their levels were increased in LUAD cells with high HSPE1 expression. Suppression of aerobic glycolysis by 2-DG attenuated the promoting effects of HSPE1 overexpression on the proliferation, migration, and invasion of LUAD cells. HSPE1 knockdown inhibited tumor growth and decreased expression levels of HK2, LADH, and GLUT1 in vivo.
Conclusion: HSPE1 regulated the proliferation, migration, and invasion of LUAD cells through the aerobic glycolysis pathway, thus facilitating malignant development of LUAD. The study suggested that HSPE1 could be useful as a therapeutic target for LUAD.
Keywords: Aerobic glycolysis; HSPE1; Lung adenocarcinoma; Malignant progression.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest none.
Similar articles
-
[GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway].Zhongguo Fei Ai Za Zhi. 2024 Oct 20;27(10):735-744. doi: 10.3779/j.issn.1009-3419.2024.101.27. Zhongguo Fei Ai Za Zhi. 2024. PMID: 39631830 Free PMC article. Chinese.
-
CCT6A facilitates lung adenocarcinoma progression and glycolysis via STAT1/HK2 axis.J Transl Med. 2024 May 15;22(1):460. doi: 10.1186/s12967-024-05284-7. J Transl Med. 2024. PMID: 38750462 Free PMC article.
-
Transcription Factor FOXA1 Facilitates Glycolysis and Proliferation of Lung Adenocarcinoma via Activation of TEX19.Mol Biotechnol. 2024 Aug;66(8):2144-2154. doi: 10.1007/s12033-023-00848-2. Epub 2023 Aug 22. Mol Biotechnol. 2024. PMID: 37606876
-
Ubiquitin-specific protease 54 regulates GLUT1-mediated aerobic glycolysis to inhibit lung adenocarcinoma progression by modifying p53 degradation.Oncogene. 2024 Jun;43(26):2025-2037. doi: 10.1038/s41388-024-03047-8. Epub 2024 May 14. Oncogene. 2024. PMID: 38744954
-
TFAP2A Upregulates SKA3 to Promote Glycolysis and Reduce the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin.Pharmacology. 2024;109(4):202-215. doi: 10.1159/000536557. Epub 2024 Apr 22. Pharmacology. 2024. PMID: 38643755
Cited by
-
GART promotes the proliferation and migration of human non-small cell lung cancer cell lines A549 and H1299 by targeting PAICS-Akt-β-catenin pathway.Front Oncol. 2025 Mar 25;15:1543463. doi: 10.3389/fonc.2025.1543463. eCollection 2025. Front Oncol. 2025. PMID: 40201340 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous